NIH K24 Midcareer Investigator Award Guide
Updated 5 official sources
Quick Answer: Eligibility turns on 8 checks: midcareer status, health-professional doctorate, active independent patient-oriented research funding, mentoring record, protected effort, trial role, institute participation, and route fit.
Full answer and how we checked it
This guide is for clinician-scientists, department chairs, sponsored-research offices, and research administrators checking NIH K24 midcareer investigator award eligibility before drafting. According to NIMH, the protected effort range is 3 to 6 person-months, or 25% to 50% full-time professional effort.
Who this is for: This guide is for clinician-scientists, department chairs, sponsored-research offices, and research administrators checking whether PA-24-188 is the right K24 route before drafting the candidate statement, mentoring plan, and protected-time case.
Data note: This guide uses NIH PA-24-188 (opens in a new tab), the NIMH K24 guidance page (opens in a new tab), NIH K24 activity-code information (opens in a new tab), NIH standard due dates (opens in a new tab), Grants.gov listing 353793 (opens in a new tab), and Grantsights award-data signals checked on June 18, 2026.
Source review by Grantsights, June 18, 2026: We rechecked NIH PA-24-188, NIMH K24 guidance, NIH K24 activity-code information, NIH standard due dates, Grants.gov 353793, and the live K24 companion program records. Where official sources stop: According to NIH PA-24-188, the notice remains the no-independent-trial branch, while the K24 family also has clinical-trial-required and basic-experimental-human branches. According to NIH standard due dates, the October 12, 2026 new-application date is too close for a team starting now, so most new K24 teams should plan around February 12, 2027 unless the target institute gives different timing. Based on our analysis, a bad fit is a senior clinician seeking salary relief without active patient-oriented research support, named mentees, a real 25% to 50% effort shift, and institute fit. For example, a clinician-scientist with funded patient-oriented research and junior investigators to mentor may fit K24, while a newer investigator should compare K23, K08, K01, K99/R00, or R01.
In this guide
- Current K24 Route Answer
- June 2026 Source Check: K24 Branch, Effort, and Due-Date Lane
- 8 NIH K24 Eligibility Checks
- What NIH Doesnt Tell You
- 3 K24 Branches: PA-24-188 vs PA-24-187 vs PA-24-189
- 5 Candidate Fit Checks
- Protected Effort: 25% to 50% Has to Be Real
- 5 Patient-Oriented Research Fit Questions
- 5 Mentoring Plan Proof Points
- 6 Budget and Award Data Signals
- 8 Application Readiness Items
- 6 Route Choice Tests
- 3 Common Failure Modes
- 5 FAQ Answers
- Sources
Quick Facts
- Agency
- HHS
- Deadline
- Nov 13, 2027
- Status
- Open
Assistance Listing 93.313: all awards
Source: USASpending.gov FY2024These figures cover all National Institutes of Health awards under Assistance Listing 93.313, of every award type. They are not figures for the award this guide describes, and one award of that kind can be far smaller.
- Total Awards (FY2024, whole listing)
- 6
- Avg Award (whole listing)
- $2,220,685
- Median Award (whole listing)
- $2,735,186
Data last verified: May 20, 2026
According to NIH PA-24-188 (opens in a new tab), the Midcareer Investigator Award in Patient-Oriented Research supports midcareer health-professional doctorates who need protected time for patient-oriented research and mentoring junior clinical investigators. The live Parent K24 program record for projects without an independent clinical trial is the best companion page for current status, award data, deadlines, and application links.
From Manusights, our sister product
Planning a K award? Manusights offers an AI critique of your application against NIH's published review criteria: $149 for a K99 or any other K award. Back within 3 business days of your upload.
Order a grant reviewCurrent K24 Route Answer
| Question | Current answer | Next action |
|---|---|---|
| Is PA-24-188 the right branch? | Yes only when the candidate will not lead an independent clinical trial. | Compare the no-trial, required-trial, and basic-experimental K24 records before drafting. |
| What is the next clean date? | The October 12, 2026 new K-series date is too close to prepare for; February 12, 2027 is the next realistic new-application date. | Use November 12, 2026 or March 12, 2027 only for allowed renewal, resubmission, or revision work. |
| What effort must be real? | NIMH describes 3 to 6 person-months, or 25% to 50% full-time professional effort. | Get the department letter and budget math aligned before the candidate statement. |
| Who should stop? | A clinician without active patient-oriented research support, named mentees, and protected time is a weak fit. | Compare K23, K08, K01, K99/R00, or R01 instead. |
The key question is not simply "Does the investigator mentor others?" It is "Does this investigator already have the independent patient-oriented research base, mentoring record, and protected-time need that make a K24 defensible?" K24 is not an early-career award. It is also not a generic salary-support award for a busy clinician.
Use this guide with the live K24 no-trial-lead program record, the live K24 clinical-trial-required program record, the live K24 basic experimental studies program record, the NIH grants complete guide, the NIH K99/R00 guide, the NIH K01 guide, the NIH fellowship guide, the NIH R01 success-rate guide, and the Grantsights grant database.
Last updated: June 18, 2026
June 2026 Source Check: K24 Branch, Effort, and Due-Date Lane
| Source checked | Current fact that affects the route | Applicant action |
|---|---|---|
| NIH PA-24-188 | PA-24-188 is the K24 independent clinical trial not allowed branch and expires in May 2027. | Use this branch only when the candidate will not lead an independent clinical trial. |
| NIH standard due dates | New K-series dates are February 12, June 12, and October 12; for a team starting now, the next realistic new-application date is February 12, 2027. | Use November 12, 2026 or March 12, 2027 only for allowed renewal, resubmission, or revision work; use February 12, 2027 for most new K24 planning. |
| NIMH K24 guidance | NIMH describes 3 to 6 person-months, or 25% to 50% full-time effort, and says the qualifying research project grant must remain active. | Check the active patient-oriented research base before writing the mentoring plan. |
| NIH K24 activity code | NIH describes K24 as protected time for midcareer health-professional doctorates who mentor clinical residents, fellows, or junior clinical faculty. | Do not use K24 as a general senior-clinician salary route. |
Related program records: Use the K24 no-trial program record, K24 required-trial record, K24 basic-experimental record, and the NIH K awards hub before drafting.
8 NIH K24 Eligibility Checks
Within 14 days, run this 8-part checklist. If any of the first 4 checks fail, pause before writing.
| Stop check | Strong K24 signal | Red flag |
|---|---|---|
| Career stage | Midcareer investigator with an established patient-oriented research record | Postdoc, new assistant professor, or investigator still seeking first independent award |
| Degree and role | Health-professional doctorate with clinical research leadership | Researcher without the patient-oriented clinical investigator role |
| Active research base | Ongoing independent patient-oriented research support | No active qualifying research funding |
| Mentoring proof | Named junior clinical investigators, outcomes, and a plan for deeper mentorship | General trainee interaction without concrete mentoring record |
| Protected effort | 3 to 6 person-months can be protected each year | Clinical, teaching, or administrative duties make the effort plan implausible |
| Trial boundary | Candidate will not lead an independent clinical trial under PA-24-188 | Candidate plans to lead the trial |
| Institute fit | A participating NIH Institute or Center fits the science and career plan | Applicant assumes every institute uses K24 the same way |
| Route choice | K24 beats K23, K99/R00, K08, K01, R01, and the K24 companion notices | The team chose K24 only because it sounds senior |
What NIH Doesnt Tell You
According to NIH PA-24-188, K24 supports protected time for patient-oriented research and mentoring. PA-24-188 gives the official terms, but 3 hard parts sit between the notice and a fundable case: proving the candidate is truly midcareer, proving the mentoring plan is more than ordinary lab supervision, and proving 25% to 50% protected effort will be real. A K24 reviewer is not just checking whether the applicant is busy and productive. The reviewer is asking whether protected time will change the applicant's mentoring output and patient-oriented research program.
The key difference from a research project grant is the center of gravity. An R01 funds a project. A K24 funds the protected time and mentoring role of a midcareer investigator who already has a patient-oriented research base. If the application reads like an R01 with a mentoring appendix, it is likely to feel misframed.
The second hidden issue is institute culture. The parent notice exists across participating NIH components, but institute pages and contacts matter. NIMH, NHLBI, NIAID, and other institutes may emphasize different research areas, salary rules, and program-contact expectations. Before writing, confirm the participating institute, contact the program official, and ask whether the specific patient-oriented research and mentoring plan fits that institute's K24 use case.
Career-award applications that struggle are often technically eligible but strategically thin. A typical gap is a candidate with several mentored trainees but no clear protected-effort swap from clinical time to patient-oriented research time. The concept can sound senior enough for K24 while the chair letter fails to prove what will stop happening after the award. That is the kind of gap reviewers notice quickly.
3 K24 Branches: PA-24-188 vs PA-24-187 vs PA-24-189
Use this 30-minute branch check before drafting because a wrong K24 branch can waste 9 to 12 months of application time.
The 3 parent K24 branches are not interchangeable.
| Route | Use when | Stop signal |
|---|---|---|
| PA-24-188, independent clinical trial not allowed | The candidate needs protected time for patient-oriented research and mentoring but will not lead an independent clinical trial | Candidate proposes to lead the clinical trial |
| PA-24-187, independent clinical trial required | The candidate will lead an independent clinical trial as part of the K24-supported work | Trial leadership is absent or belongs to another PI |
| PA-24-189, basic experimental studies with humans required | The work is a basic experimental study with humans under NIH's clinical-trial policy | The study is ordinary patient-oriented clinical research or a full clinical trial |
PA-24-188 can still allow experience in a clinical trial led by another investigator. That is different from leading the trial. According to NIH PA-24-188, the candidate may gain clinical-trial experience in a trial led by another investigator, but cannot lead an independent clinical trial. If the candidate is responsible for intervention assignment, trial conduct, and the independent clinical trial aims, use the clinical-trial-required branch instead.
5 Candidate Fit Checks
The K24 applicant needs to be far enough along to mentor others from a base of active patient-oriented research. The 5 strongest files usually show:
- Peer-reviewed patient-oriented research funding.
- A publication record tied to human subjects, human material, or direct clinical interaction.
- Junior clinical investigators who need the candidate's mentorship.
- Prior trainees, fellows, residents, or junior faculty with measurable outputs.
- A realistic protected-time plan that the department can honor.
If the candidate is early-career, the better route may be K23, K08, K01, K99/R00, or R01 depending on degree, research focus, independence status, and preliminary data. K24 should not be used to skip the early-career pathway. Use the NIH K99/R00 guide when the applicant is still moving from postdoc to faculty, and use the NIH K01 guide when the issue is mentored career growth rather than midcareer mentoring leadership.
Protected Effort: 25% to 50% Has to Be Real
According to the NIMH K24 guidance page (opens in a new tab), applicants must show the need for protected time, 3 to 6 person-months, or 25% to 50% full-time professional effort. That effort is not a bookkeeping detail. It is the logic of the award.
A strong protected-time case names what will change:
- Which clinical, administrative, or teaching duties will be reduced.
- Which patient-oriented research aims will be protected.
- Which junior investigators will be mentored.
- Which manuscripts, protocols, training products, or grant submissions are expected.
- Who at the institution has authority to protect the time.
Weak applications say the investigator is busy and needs time. Strong applications show exactly how the protected time will be converted into research and mentoring outputs. Make a 1-page effort map before writing the candidate statement: current duties, duties reduced, percent effort protected, mentoring outputs, and the institutional owner for each change. If you do not know what will move off the candidate's calendar, you do not have a protected-time plan yet.
5 Patient-Oriented Research Fit Questions
Use these 5 questions in the first 7 days of route selection, before the team starts writing aims or mentoring text.
NIH frames patient-oriented research around work with human subjects or human material where the investigator or colleagues interact directly with people. For K24, the research base should not be a purely basic-science portfolio with occasional clinical relevance. The strongest fit is an investigator whose ongoing work involves clinical questions, patient data, human specimens, interventions, outcomes, or health services questions tied to patients.
Ask 5 questions before choosing K24:
- Is the candidate's funded work truly patient-oriented?
- Can the candidate explain why protected time will improve that work?
- Are junior clinical investigators central to the plan?
- Does the department support the protected-time arrangement?
- Does the target institute participate in and value this K24 use case?
If the answer to any question is weak, fix that gap before drafting.
5 Mentoring Plan Proof Points
Use these 5 proof points to turn a mentoring claim into a 12-month operating plan reviewers can picture.
K24 mentoring is not just office hours. The mentoring plan should show a system. Reviewers need to see who the junior investigators are, what they need, how often they will meet, what products they will produce, and how the K24 candidate is uniquely positioned to help.
Strong mentoring plans include:
- Named mentee types: fellows, residents, junior faculty, clinical investigators, or scholars.
- Milestones: abstracts, manuscripts, protocols, career award submissions, R01 submissions, or pilot awards.
- Structure: meeting cadence, review process, authorship norms, and responsible conduct of research integration.
- Outcome tracking: publications, grant submissions, retention in patient-oriented research, and career progress.
- Institutional backing: department chair support, protected time, training resources, and access to clinical research infrastructure.
The plan should not overpromise. A K24 applicant who lists too many mentees without a credible cadence can look unfocused. A tighter plan names a few primary mentees and treats the other names as pipeline context. That plan is easier to read when every mentee has a product, meeting rhythm, and career-stage reason for needing the K24 candidate.
6 Budget and Award Data Signals
NIH K24 budget rules vary by Institute or Center. Applicants should not assume the salary cap, research support, or allowable costs are identical across NIH. Start with PA-24-188, then check the participating institute's K24 page or contact.
According to NIMH K24 guidance, applicants must show the need for 3 to 6 person-months of protected time, which means the budget narrative and department letter need to agree.
Check 6 budget signals before submission:
| Signal | What to verify | Why it matters |
|---|---|---|
| Salary base | Institutional base salary and NIH salary-cap treatment | The award cannot fix an unclear salary calculation |
| Effort | 25% to 50% protected effort | The budget has to match the career plan |
| Research support | Institute-specific research-cost rules | Each NIH component may set its own limits |
| Department support | What duties are reduced | Reviewers need proof that protected time exists |
| Active grants | How existing awards support the K24 case | K24 depends on an active research base |
| Mentee costs | Travel, supplies, or other support if allowed | Mentoring claims should match actual resources |
8 Application Readiness Items
Use this 8-item file check at least 6 weeks before the receipt date so chair letters, effort math, and program-contact notes agree.
Before the team writes the candidate statement, collect these items:
- Current NIH biosketch with patient-oriented research and mentoring evidence.
- List of active research grants and how each supports the K24 case.
- Mentee roster with role, stage, project, and target product.
- Department letter that states what duties will be reduced.
- Protected-effort budget logic checked against institute rules.
- Route memo comparing PA-24-188, PA-24-187, PA-24-189, K23, K08, K01, K99/R00, and R01.
- Program-officer notes from the target institute.
- Clinical-trial role memo showing why PA-24-188 is the correct branch.
- Current institute contact notes, including the name and date of the program conversation.
- Draft mentoring table with no more than 4 to 6 primary mentees unless the cadence can support more.
6 Route Choice Tests
Use these 6 route tests in a 1-page memo before the specific aims page is drafted.
Use K24 when the candidate is already a funded patient-oriented investigator and the primary need is protected time for research and mentoring. Use K23 when the applicant is still being mentored toward independence in patient-oriented research. Use K08 when the applicant is a clinician-scientist seeking mentored basic or translational research training. Use K99/R00 for postdoctoral transition to independence. Use R01 when the main need is project funding and the investigator can support mentoring without K24 protected time.
This route memo is worth writing before the specific aims page. It prevents teams from choosing K24 because it sounds prestigious rather than because it is the best fit. For broader context on project funding, compare the K24 case with the NIH R01 success-rate guide. For earlier training routes, compare the applicant against the NIH fellowship guide. If you're still debating K24 versus K23, you're probably debating whether the applicant is already an independent mentor or still needs a mentored career route.
| If the main problem is... | Better first comparison |
|---|---|
| Early clinician-scientist training | K23 or K08 |
| Postdoc-to-faculty transition | K99/R00 |
| Independent research project funding | R01 |
| Institution-run trainee slots | T32 |
| Midcareer mentoring plus patient-oriented research time | K24 |
| Candidate-led independent trial | PA-24-187, not PA-24-188 |
3 Common Failure Modes
The first failure mode is weak protected effort. The application says 25% to 50% effort, but the chair letter does not explain which duties will change. The second failure mode is weak mentoring proof. The candidate lists trainees but does not show outcomes, products, or mentoring cadence. The third failure mode is the wrong clinical-trial branch. PA-24-188 can fit clinical-trial experience under another PI, but it does not fit an applicant-led independent clinical trial.
Write a 1-page branch memo before the aims page. The memo should name PA-24-188, PA-24-187, and PA-24-189; state who leads the trial if any; and explain why the no-trial-lead branch is correct. It's a small document, but it can prevent a months-long drafting mistake. Don't skip it, because you'll usually find the branch error before the team has invested in the wrong narrative.
5 FAQ Answers
These 5 answers cover the highest-intent K24 questions searchers ask before opening ASSIST.
Is PA-24-188 open now?
Yes. The Grants.gov listing and NIH notice should be checked before submission, but the current Grantsights program record shows the opportunity as open with a listed expiration in 2027.
Can a K24 applicant lead a clinical trial under PA-24-188?
No. PA-24-188 is the independent clinical trial not allowed branch. The candidate may gain experience in another investigator's trial, but an applicant-led independent clinical trial belongs in the clinical-trial-required branch.
Does a K24 replace an R01?
No. K24 is career award support for protected patient-oriented research and mentoring time. The applicant still needs an independent patient-oriented research base.
Is K24 for early-career investigators?
No. Early-career clinician-scientists usually compare K23, K08, K01, K99/R00, R03, R21, and R01 routes before considering K24.
What should a team do first?
Confirm institute participation, verify the clinical-trial branch, map the protected effort, list the mentees, and review the live K24 no-trial-lead program record before drafting.
Sources
NIH K24 route chooser
Decide whether this is K24 no-trial, K24 trial-required, another K award, or a project grant
K24 searches mix midcareer patient-oriented research, trial-lane checks, mentoring duties, other K awards, and R-series project routes. Pick the path before writing the candidate, mentor, and protected-time plan.
K24 no-trial route
Use this when the midcareer clinician-scientist will not lead an independent clinical trial.
Open the program pageNext stepK24 clinical-trial route
Use this when the candidate will lead an independent clinical trial, feasibility study, or ancillary trial.
Open the program pageNext stepK24 BESH route
Use this when the work is a basic experimental study with humans under the K24 companion route.
Open the program pageNext stepCompare K awards
Use this when the candidate may fit K23, K08, K01, K25, K99/R00, K07, or another career award.
See NIH K awardsNext stepCompare NIH mechanisms
Use this when the main need may be R01, R21, R03, or another project route instead of K24.
Read the guideNext stepFind grants that fit you
Free eligibility check: answer 12 questions and see ranked matches with deadlines and fit reasons.
Check eligibilityK24 fit
The candidate is midcareer, has active patient-oriented research support, mentors junior investigators, and can protect 25% to 50% effort.
Other K fit
The applicant needs mentored development, career transition, quantitative training, or another career-stage route.
Project-grant fit
The main need is research-project funding, not protected time for patient-oriented research and mentoring.
Largest awards active in FY2024
One row per recipient, its largest award | 6 Assistance Listing records | Avg: $2.2M
Augusta University Research Institute, Inc
GA
University of North Carolina at Chapel Hill
NC
Use the visible recipient rows as free source context
This program has no reviewed paid report today.
No reviewed paid report is currently offered for this program. The visible source rows remain free.
Last updated October 10, 2026. Corrected October 10, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.
Related Guides
Complete Guide
NIH Grants 2026: R01, K Awards, R21, R35, SBIR
Compare NIH R01, K awards, R21, R03, R35, SBIR/STTR, success rates, deadlines, and program pages before choosing a route.
NIH New Innovator Award (DP2) Winners 2026
All 42 NIH Director's New Innovator Award (DP2) winners for 2026 from RePORTER, with award amounts, institutions, institutes and the FY2019-FY2026 trend.
NIH F31 Fellowship Recipients and Award History
NIH F31 fellowship recipients in RePORTER: 923 new F31 awards in FY2026, a $46,320 median first-year award, and the top schools, states and institutes.
NIH F32 Fellowship Recipients and Award History
NIH F32 recipients in RePORTER: 212 new F32 postdoc fellowships in FY2026, down 58% from FY2020, with award amounts, top schools and institutes.
NIH K01, K08, K23 Success Rates by Institute
The NIH K01 success rate fell to 22.5% in FY2025, K08 to 29.7% and K23 to 30.5%. See rates by institute, FY2026 award counts, and the K01 payline.
NIH K01 Grant 2026: Eligibility, Salary, Page Limits
NIH K01 grant: 3 to 5 years at 75% effort, $75,000 to $100,000 salary at most institutes, NIAID rules, the 12-page limit and the Feb 12, 2027 due date.